Latest NewAmsterdam Pharma News & Updates

See the latest news and media coverage for NewAmsterdam Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
NewAmsterdam Pharma

Biopharmaceutical company developing cardiovascular and lipid-related treatments

newamsterdampharma.com
Headquarters
Aventura, United States
Founded year
2019
Company type
Public company
Number of employees
120–200
Industry
Pharmaceuticals

Last updated

Latest news about NewAmsterdam Pharma

Company announcements

NewAmsterdam Pharma

NewAmsterdam Pharma and Menarini receive European Commission approval for obicetrapib

The European Commission authorizes Ubeslo monotherapy and Evlarco fixed-dose combination for elevated LDL-C, marking obicetrapib's first global regulatory approval.

Unlock all announcements with a

Media coverage

The Manila Times

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NAARDEN, the Netherlands and MIAMI, May 07, 2026 (GLOBE NEWSWIRE)-- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam” or the "Company”), a late-stage, clinical biopharmaceutical...

Unlock all articles with a

Never miss news about NewAmsterdam Pharma

Track NewAmsterdam Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.